These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10720212)

  • 1. The effect of hemodiafiltration with on-line endogenous reinfusion (on-line HFR) on anemia: design of a European, open, randomised, multicentre trial. European Collaborative Study.
    J Nephrol; 2000; 13(1):34-42. PubMed ID: 10720212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A single centre study about the effects of HFR on anemia].
    Righetti M; Ferrario GM; Milani S; Serbelloni P; Sessa A
    G Ital Nefrol; 2004; 21 Suppl 30():S168-71. PubMed ID: 15750978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.
    Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Filippi C; Mantuano E; Sidoti A; Grazi G; Antonelli A; Angelini D; Petrone I; Mura C; Tolaini P; Saloi F; Ghezzi PM; Barsotti G; Palla R
    Nephrol Dial Transplant; 2006 Mar; 21(3):756-62. PubMed ID: 16303780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch from bicarbonate hemodialysis to hemodiafiltration with online regeneration of the ultrafiltrate (HFR): effects on nutritional status, microinflammation, and beta-microglobulin.
    Bossola M; Muscaritoli M; Tazza L; Giungi S; Panocchia N; Rossi Fanelli F; Luciani G
    Artif Organs; 2005 Mar; 29(3):259-63. PubMed ID: 15725229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C; Vernaglione L; Perniola MA; Lo Barco C; Muscogiuri P; Chimienti S
    G Ital Nefrol; 2004; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspects of the on-line hemodiafiltration with regeneration and reinfusion of the ultrafiltrate (HFR): multicenter study].
    De Simone W; De Simone M; De Simone A; Iannaccone S; Manganelli R; Zito B; Guastaferro P; Apperti V; Paglionico C; Salvati G; Veniero P; Ferro F; Tedesco V
    G Ital Nefrol; 2004; 21 Suppl 30():S161-7. PubMed ID: 15750977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [On-line hemodiafiltration with endogenous reinfusion (HFR). Experience of a Centre].
    Ballabeni C; Maccario M; Ciurlino D; Martino S; Tentori F; Bigatti G; Bertoli SV
    G Ital Nefrol; 2004; 21 Suppl 30():S181-4. PubMed ID: 15750981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute biocompatibility of hemodiafiltration with endogenous reinfusion (HFR)].
    Aucella F; Gesuete A; Sereni L; Netti S; Savastano AM; Querques M; Specchio A; De Min A; Avanzi C; Montemurno C; Grandone E; Cappucci F; Procaccini DA; Stallone C; Gesualdo L;
    G Ital Nefrol; 2004; 21 Suppl 30():S185-9. PubMed ID: 15750982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-replete hemodialysis patients do not require higher EPO dosages when converting from subcutaneous to intravenous administration: results of the Italian Study on Erythropoietin Converting (ISEC).
    Pizzarelli F; David S; Sala P; Icardi A; Casani A
    Am J Kidney Dis; 2006 Jun; 47(6):1027-35. PubMed ID: 16731298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines for the treatment of anemia in chronic renal failure].
    Triolo G;
    G Ital Nefrol; 2003; 20 Suppl 24():S61-82. PubMed ID: 14666504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
    Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
    Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two-chamber hemodiafiltration: comparison between exogenous reinfusion (PFD) and endogenous reinfusion (HFR)].
    Schelotto C; Santoni O; Nasini MG; Pietrucci A; Caviglia PM; Tirotta A; Repetto M; Carozzi S
    G Ital Nefrol; 2004; 21 Suppl 30():S111-6. PubMed ID: 15747292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The hemodiafiltration with endogenous reinfusion reduces the erythroid progenitor inhibition by uremic serum].
    Aucella F; Scalzulli RP; Vigilante M; Stallone C
    G Ital Nefrol; 2004; 21 Suppl 30():S128-32. PubMed ID: 15750970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodiafiltration with endogenous reinfusion with and without acetate-free dialysis solutions: effect on ESA requirement.
    Bolasco PG; Ghezzi PM; Serra A; Corazza L; Murtas S; Mascia M; Cossu M; Ferrara R; Cogoni G; Cadinu F; Casu D; Contu B; Passaghe M; Ghisu T; Ganadu M; Logias F
    Blood Purif; 2011; 31(4):235-42. PubMed ID: 21242676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A; Covic A; Locatelli F; Macdougall IC;
    Ren Fail; 2008; 30(3):267-76. PubMed ID: 18350446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HFR vs HDF-ON line: plasmatic amino acids loss evaluation].
    Ragazzoni E; Carpani P; Agliata S; Ciranna G; Cusinato S; Albini M; Cavagnino A
    G Ital Nefrol; 2004; 21 Suppl 30():S85-90. PubMed ID: 15747313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [On-line haemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: Beta2-microglobulin removal versus filtration fraction].
    Emiliani G; Briganti M; Montanari A; Isola E; Fusaroli M
    G Ital Nefrol; 2004; 21 Suppl 30():S80-4. PubMed ID: 15747312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.